SEC 13F Intelligence

Rtw Investments, LP / IMCR

Rtw Investments, LP’s Immunocore Hldgs PLC Position

Does Rtw Investments, LP own Immunocore Hldgs PLC (IMCR)? Yes4.87M shares worth $147M (+1.46% of its 13F portfolio) as of Q1 2026.

Position Value
$147M
Q1 2026
Shares
4.87M
% of Portfolio
+1.46%
Quarters Held
21
currently held

Position History IMCR

Reported value by quarter
Q1 ’21: $50MQ1 ’21Q2 ’21: $48MQ3 ’21: $46MQ4 ’21: $43MQ4 ’21Q1 ’22: $56MQ2 ’22: $149MQ3 ’22: $209MQ3 ’22Q4 ’22: $317MQ1 ’23: $279MQ2 ’23: $362MQ2 ’23Q3 ’23: $316MQ4 ’23: $417MQ1 ’24: $391MQ1 ’24Q2 ’24: $165MQ3 ’24: $152MQ4 ’24: $144MQ4 ’24Q1 ’25: $144MQ2 ’25: $153MQ3 ’25: $177MQ3 ’25Q4 ’25: $169MQ1 ’26: $147Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.87M$147M+1.46%
Q4 20254.87M$169M+1.69%
Q3 20254.87M$177M+2.18%
Q2 20254.87M$153M+2.18%
Q1 20254.87M$144M+2.21%
Q4 20244.87M$144M+2.17%
Q3 20244.87M$152M+2.19%
Q2 20244.87M$165M+2.56%
Q1 20246.02M$391M+5.78%
Q4 20236.10M$417M+6.51%
Q3 20236.10M$316M+6.68%
Q2 20236.03M$362M+6.88%
Q1 20235.65M$279M+5.82%
Q4 20225.56M$317M+6.48%
Q3 20224.45M$209M+4.82%
Q2 20224.00M$149M+3.85%
Q1 20221.86M$56M+1.15%
Q4 20211.25M$43M+0.62%
Q3 20211.25M$46M+0.70%
Q2 20211.25M$48M+0.72%
Q1 20211.25M$50M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of IMCR.